Originally published In Press as doi:10.1074/jbc.M204694200 on August 20, 2002
J. Biol. Chem., Vol. 277, Issue 44, 41342-41351, November 1, 2002
Complement C5b-9 Membrane Attack Complex Increases Expression
of Endoplasmic Reticulum Stress Proteins in Glomerular Epithelial
Cells*
Andrey V.
Cybulsky
§¶,
Tomoko
Takano
,
Joan
Papillon
,
Abdelkrim
Khadir
,
Jianhong
Liu
§**, and
Hongwei
Peng

From the
Department of Medicine, McGill University
Health Centre, and § Department of Physiology, McGill
University, Montreal, Quebec H3A 1A1, Canada
Received for publication, May 14, 2002, and in revised form, July 22, 2002
 |
ABSTRACT |
In the passive Heymann nephritis (PHN) model of
membranous nephropathy, complement C5b-9 induces glomerular epithelial
cell (GEC) injury, proteinuria, and activation of cytosolic
phospholipase A2 (cPLA2). This study
addresses the role of endoplasmic reticulum (ER) stress proteins (bip,
grp94) in GEC injury. GEC that overexpress cPLA2 (produced
by transfection) and "neo" GEC (which expresses cPLA2
at a lower level) were incubated with complement (40 min), and leakage
of constitutively expressed bip and grp94 from ER into cytosol was
measured to monitor ER injury. Greater leakage of bip and grp94
occurred in complement-treated GEC that overexpress cPLA2,
as compared with neo, implying that cPLA2 activation
perturbed ER membrane integrity. After chronic incubation (4-24 h),
C5b-9 increased bip and grp94 mRNAs and proteins, and the increases were dependent on cPLA2. Expression of bip-antisense
mRNA reduced stimulated bip protein expression and enhanced
complement-dependent GEC injury. Glomerular bip and grp94
proteins were up-regulated in proteinuric rats with PHN, as compared
with normal control. Pretreatment of rats with tunicamycin or
adriamycin, which increase ER stress protein expression, reduced
proteinuria in PHN. Thus, C5b-9 injures the ER and enhances ER stress
protein expression, in part, via activation of cPLA2. ER
stress protein induction is a novel mechanism of protection from
complement attack.
 |
INTRODUCTION |
Activation of the complement cascade near a cell surface leads to
assembly of terminal components, exposure of hydrophobic domains, and
insertion of the C5b-9 membrane attack complex into the lipid bilayer
of the plasma membrane (1, 2). Assembly of C5b-9 results in formation
of transmembrane channels or rearrangement of membrane lipids with loss
of membrane integrity. Nucleated cells require multiple C5b-9 lesions
for lysis, but at lower doses, C5b-9 induces sublethal (sublytic)
injury and various metabolic effects (1-8). An example of sublytic
C5b-9-mediated cell injury in vivo is passive Heymann
nephritis (PHN)1 in the rat,
a widely accepted model of human membranous nephropathy (9). In PHN,
antibody binds to visceral glomerular epithelial cell (GEC) antigens
and leads to the in situ formation of subepithelial immune
complexes (9, 10). C5b-9 assembles in GEC plasma membranes, "activates" GEC, and leads to proteinuria and sublytic GEC injury (9-14). Based on studies in GEC culture and in vivo, C5b-9
assembly induces transactivation of receptor tyrosine kinases (15), an increase in cytosolic free Ca2+ concentration
([Ca2+]i), and activation of protein kinase C, as
well as cytosolic phospholipase A2-
(cPLA2)
(16-19). cPLA2 is an important mediator of
C5b-9-dependent GEC injury. First, arachidonic acid (AA)
released by cPLA2 is metabolized in GEC via
cyclooxygenases-1 and -2 to prostaglandin E2 and
thromboxane A2 (20), and inhibition of prostanoid
production reduces proteinuria in PHN (21-25) and in human membranous
nephropathy (26). Second, cPLA2 may mediate GEC injury more
directly (16).
cPLA2 (group IV PLA2) is regulated by
[Ca2+]i and phosphorylation (27, 28). Stimuli
that raise [Ca2+]i in the submicromolar range may
induce translocation of cPLA2 from cytosol to an
intracellular membrane, where cPLA2 would bind via its
N-terminal Ca2+-dependent lipid binding or
C2 domain, gaining access to phospholipid substrate. We have
demonstrated that cPLA2 is the major PLA2 in GEC and that complement enhances cPLA2 phosphorylation and
catalytic activity (16). Moreover, C5b-9 increases free AA in GEC, and release of AA is amplified by overexpression of cPLA2 (16,
17). Recently, we demonstrated that cPLA2 localizes and
hydrolyzes phospholipids at the plasma membrane in GEC, the
membrane of the endoplasmic reticulum (ER), and the nuclear envelope
but not at mitochondria or Golgi (29). Thus, the activation of
cPLA2 and release of AA are compartmentalized to specific
organelles, but it is presently unknown if hydrolysis of membrane
phospholipids by cPLA2 leads to injury of these organelles
in GEC.
Based on studies in cell culture, complement attack may injure cells
but may also activate pathways that restrict injury or facilitate
recovery. One mechanism of protection from complement attack is
"ectocytosis" (shedding) of C5b-9 complexes from cell membranes (1,
2). There are undoubtedly other recovery mechanisms that require
delineation. For example, exposure of cells to environmental stress
increases expression of stress proteins in cellular compartments such
as the ER. There are several types of ER stress responses, including
the "unfolded protein response" (30-32). ER stress proteins are
believed to be induced by accumulation of abnormal proteins or
depletion of ER Ca2+ stores and include the glucose-related
proteins (grp), grp94, bip (grp78), and erp72. Tunicamycin, a
nucleoside antibiotic that blocks N-linked glycosylation and
is believed to cause an accumulation of unfolded proteins in the ER,
and the Ca2+ ionophore, ionomycin, which can deplete
Ca2+ from intracellular stores, can induce ER stress
proteins (30-32). Under normal conditions, ER stress proteins might
serve as protein chaperones for exocytosis from ER, and they might
complex with defective proteins and target them for degradation. During
stress, the induction of ER stress proteins may limit accumulation of abnormal proteins in cells (31, 32). Generally, regulation of ER stress
proteins appears to be controlled at the transcriptional level, and
requires several hours and de novo protein synthesis. Moreover, exposure of cells to mild stress, which induces ER stress proteins, may be protective to additional insults (33, 34), although
prolonged or more substantial ER stress may lead to cell death by
apoptosis (35).
The aim of the present study was to determine if C5b-9-mediated
activation of cPLA2 and GEC injury are associated with
induction of the ER unfolded protein response. We demonstrate that
C5b-9 may damage the ER and enhance expression of ER stress proteins via activation of cPLA2. Induction of ER stress proteins
limits complement-dependent GEC injury in culture and in
PHN.
 |
EXPERIMENTAL PROCEDURES |
Materials
Tissue culture media, TRIzol reagent, and a Random Primer DNA
Labeling System were obtained from Invitrogen (Burlington, Ontario). Complement-deficient sera and purified C8 were purchased from Quidel
(San Diego, CA). [3H]AA (100 Ci/mmol) and
[
-32P]dCTP (3000 Ci/mmol) were purchased from
PerkinElmer Life Sciences (Boston, MA). Adriamycin, puromycin
aminonucleoside, tunicamycin, ionomycin were from Sigma Chemical Co.
(St. Louis, MO). Methyl arachidonyl fluorophosphonate (MAFP) was from
BIOMOL (Plymouth Meeting, PA). Antibodies to bip, grp94, and erp72 were
purchased from Stressgen Biotechnologies Corp. (Victoria, BC).
Fluorescein-conjugated antibodies were from Cedarlane Laboratoires Ltd.
(Hornby, Ontario). Electrophoresis and immunoblotting reagents were
from Bio-Rad Laboratories (Mississauga, Ontario). bip cDNA
was kindly provided by Dr. M. Gething (University of
Melbourne) and grp94 and erp72 cDNAs by Dr. M. Green (St. Louis
University). bip antisense cDNA constructed in pcDNA3 was
kindly provided by Dr. J. Stevens (University of Vermont) (33).
Methods
Cell Culture and Transfection--
Rat GEC culture and
characterization has been detailed previously (36). GEC were cultured
in K1 medium on plastic substratum. The method for stable transfection
of GEC (e.g. to produce GEC that stably overexpress
cPLA2) was described previously (16, 17), and the same
method was used to produce GEC that stably expressed bip antisense
cDNA. GEC that express only the neomycin-resistance gene
(neo) were used as control. Briefly, GEC were co-transfected with the expression vector of interest, and pRc/RSV (molar ratio 12.5:1), using a CaPO4 technique. Colonies of GEC resistant
to G418 were isolated and expanded. Transfectants were selected for a
high level of cPLA2 activity and protein expression or, in
the case of bip antisense cDNA, inhibition of stimulated bip
protein expression (determined by immunoblotting). Compared with
parental or neo GEC, PLA2 activity was increased ~5-fold
in GEC that overexpress cPLA2, but was nevertheless within
a physiological range, and comparable to the level in Madin-Darby
canine kidney cells (16, 17).
Incubation of GEC with Antibody and Complement--
To activate
complement, GEC in monolayer culture were incubated with rabbit
anti-GEC antiserum (5% v/v) in modified Krebs-Henseleit buffer
containing 145 mM NaCl, 5 mM KCl, 0.5 mM MgSO4, 1 mM
Na2HPO4, 0.5 mM CaCl2,
5 mM glucose, and 20 mM Hepes, pH 7.4, for 40 min at 22 °C (16, 17). GEC were then incubated with normal human serum (diluted in Krebs-Henseleit buffer in acute incubations, or K1
medium in chronic incubations) or with heat-inactivated (decomplemented) human serum (56 °C) in controls, at 37 °C. In some experiments, antibody-sensitized GEC were incubated with C8-deficient human serum or C8-deficient serum supplemented with purified C8 (80 µg/ml undiluted serum). We have generally used heterologous complement to facilitate studies with complement-deficient sera, and to minimize possible signaling via complement-regulatory proteins, however, in earlier studies results of several experiments were confirmed with homologous (rat) complement. There was some variability in sublytic and lytic concentrations of complement among
batches of sera. In GEC, complement is not activated in the absence of
antibody, and antibody does not independently affect free
[3H]AA (16-18).
Induction and Characterization of PHN--
Sheep anti-rat Fx1A
was prepared as described previously (37). Male Sprague-Dawley rats
(150 g, Charles River, St. Constant, Quebec) were injected with 350 µl of sheep anti-Fx1A antiserum. This batch of antiserum caused
little proteinuria in the heterologous phase (day 5 or earlier) but
induced significant proteinuria in the autologous phase (days 7-14).
Rats were sacrificed at various intervals, and glomeruli were isolated
by differential sieving (37).
Immunofluorescence microscopy for sheep IgG, rat IgG, and rat C3 was
performed as described previously (11). Briefly, 4-µm cryostat kidney
sections were stained with fluorescein-conjugated IgG fractions of
monospecific antisera. The immunofluorescence signals from whole
glomeruli were evaluated using a Leitz immunofluorescence microscope
with visual output connected to a Nikon UFX-II photomultiplier and
camera, similar to a method described earlier (38). Densitometry readings were done under immersion oil, and the biopsy material was
magnified 400 times, such that the glomerular cross-section filled the
majority of the densitometry field. The time required to collect an
image from a glomerulus is inversely proportional to immunofluorescence
intensity. Times required to collect images from three representative
glomeruli in each tissue section were recorded and averaged.
Serum creatinine measurements were performed in the clinical
biochemistry laboratory of the Royal Victoria Hospital (Montreal, Quebec).
Measurement of Free [3H]AA--
GEC phospholipids
were labeled to isotopic equilibrium with [3H]AA for
48-72 h, as detailed previously (16-20). Lipids were extracted from
~1 × 106 cells and cell supernatants. Methods for
extraction and separation of radiolabeled lipids by thin layer
chromatography were published previously (16-20).
Northern Hybridization and Immunoblotting--
Northern
hybridization was performed as described previously (20). Briefly,
total RNA was extracted from GEC using the TRIzol reagent. RNA was
separated by gel electrophoresis (1% agarose containing 1.9%
formaldehyde) and was transferred to a nylon membrane. Coding regions
of rat bip, grp94, and erp72 cDNAs were radiolabeled with
[
-32P]dCTP using the Random Primer DNA Labeling
System. Membranes were hybridized in buffer containing 1% bovine serum
albumin, 7% SDS, 0.5 M sodium phosphate, pH 6.8, 1 mM EDTA, and 1-2 × 106 cpm/ml of
radiolabeled probe for 16 h at 42 °C. Membranes were washed in
buffer containing 0.5% bovine serum albumin, 5% SDS, 40 mM sodium phosphate, pH 6.8, 1 mM EDTA twice
for 20 min at 65 °C, and then buffer containing 1% SDS, 40 mM sodium phosphate, pH 6.8, 1 mM EDTA four
times for 20 min at 65 °C. Membranes were exposed to x-ray film with
an intensifying screen at
70 °C for 48-72 h.
For immunoblotting, GEC or glomerular lysates were mixed with Laemmli
sample buffer and were subjected to SDS-PAGE. Proteins were transferred
to nitrocellulose paper, blocked with 5% fat-free dry milk in 20 mM Tris, 50 mM NaCl, pH 7.5, with 0.05% Tween
20 (15-17). Blots were incubated with primary antibodies. After
washing with Tris-buffered saline/Tween 20 solution, blots were
incubated with secondary antibody and developed using the enhanced
chemiluminescence technique.
Quantification of Northern blots and immunoblots was performed by
densitometry. Blots were scanned, specific bands of interest were
selected, and the density of the bands was measured using National
Institutes of Health Image software. Results are expressed in arbitrary
units. Preliminary studies demonstrated that there was a linear
relationship between densitometric measurements and the amounts of
protein loaded onto gels.
Measurement of Complement-dependent
Cytotoxicity--
Complement-mediated cell lysis was determined by
measuring release of lactate dehydrogenase (LDH), as described
previously (15, 36). Specific release of LDH was calculated as
[NS
HIS]/[100
HIS], where NS represents the
percentage of total LDH released into cell supernatants in incubations
with normal serum, and HIS is the percentage of total LDH released into
cell supernatants in incubations with heat-inactivated serum (36).
Statistics--
Data are presented as mean ± S.E. The
t statistic was used to determine significant differences
between two groups. For more than two groups, one-way analysis of
variance was used to determine significant differences among groups,
and where significant differences were found, individual comparisons
were made between groups using the t statistic, and
adjusting the critical value according to the Bonferroni method.
Two-way analysis of variance was used to determine significant
differences in multiple measurements among groups.
 |
RESULTS |
Complement Activates cPLA2 and Induces GEC
Injury--
Incubation of GEC with antibody and complement increases
free AA (16-19). The increase is evident within 40 min, and persists for at least 24 h (217 ± 46% control at 24 h). Stable
overexpression of cPLA2 in GEC amplifies the
complement-induced increase in free AA (465 ± 183% control at
24 h) (19). Table I shows levels of
free [3H]AA in complement-treated GEC that stably
overexpress cPLA2. Incubation of antibody-sensitized GEC
with normal serum as the complement source increased
[3H]AA more than 3-fold, as compared with
heat-inactivated (decomplemented) serum. C8 is the key component of the
C5b-9 membrane attack complex. Incubation of GEC with C8-deficient
serum reconstituted with purified C8 also increased free
[3H]AA more than 3-fold, as compared with unreconstituted
C8-deficient serum or with heat-inactivated serum. Therefore,
PLA2-mediated release of AA is due to assembly of C5b-9,
whereas C5b-7 has no significant effect.
View this table:
[in this window]
[in a new window]
|
Table I
C5b-9-induced release of [3H]AA
A: [3H]AA-labeled GEC that overexpress cPLA2 were
incubated with anti-GEC antibody and normal serum (NS) at a sublytic
concentration (2.5% v/v), or heat-inactivated serum (HIS) in controls,
for 40 min at 37 °C. B: GEC were incubated with antibody and 2.5%
C8-deficient serum reconstituted with purified C8 (C8DS + C8),
C8-deficient serum alone (C8DS), or heat-inactivated serum for 40 min
at 37 °C. Lipids were extracted and [3H]AA measured by
thin-layer chromatography. Free [3H]AA is presented as the
percentage of total radioactivity.
|
|
Complement-induced activation of cPLA2 leads to
phospholipid hydrolysis at the membrane of the ER (29). We assessed
whether hydrolysis of ER membrane phospholipids may induce injury to
the ER compartment. Resting GEC express the ER stress proteins, bip and
grp94, and these proteins are localized mainly in the ER (Fig. 1). The integrity of the ER membrane was
monitored by the leakage of constitutively expressed bip and grp94,
from the ER compartment into the cytosol. Brief incubation of GEC with
complement (2.5% normal serum, 40 min) induced significant increases
in the amounts of bip or grp94 in the cytosol of the GEC that
overexpress cPLA2 (a representative immunoblot is shown in
Fig. 1A, and densitometric quantification is given in Table
IIA). The amount of bip or
grp94 in the cytosol represented only a minor proportion of
the total (<15%), and brief incubation with complement
did not induce significant increases in total ER stress protein
expression (Fig. 1). At the concentration of complement that induced
increases in bip and grp94 in the cytosol of GEC that overexpress
cPLA2, there were no significant increases in bip or grp94
in the cytosol of neo GEC (Table IIA). However, increases in
bip and grp94 could be detected in the cytosol of neo GEC when the
concentration of complement was increased (4.0% normal serum, Fig.
1B and Table IIB). These results suggest that
activation of cPLA2 by complement perturbed the ER membrane
sufficiently to allow a small portion of bip or grp94 to leak into the
cytosol. Sublytic complement did not cause bip to leak out of cells,
i.e. through the plasma membrane (not shown).

View larger version (44K):
[in this window]
[in a new window]
|
Fig. 1.
Complement-induced activation of
cPLA2 affects the integrity of the membrane of the ER.
A, neo GEC (which express a low endogenous level of
cPLA2) or GEC that overexpress cPLA2 were
incubated in duplicate with anti-GEC antibody and 2.5% normal serum
(NS; to form sublytic C5b-9), or heat-inactivated serum
(HIS) in controls, for 40 min. After collection of
supernatants, GEC plasma membranes were briefly permeabilized with
digitonin (37 µg/ml) to recover the cytosol. Then, membranes and
contents of the ER were solubilized by the addition of 1% Triton
X-100. Digitonin and Triton fractions were immunoblotted with
antibodies to bip or grp94 (in duplicate). An increase in bip and grp94
is present in the digitonin fraction of complement-treated GEC that
overexpress cPLA2 (seventh and eighth
lanes from the left). B, antibody-sensitized
neo GEC were incubated with 4.0% normal serum or heat-inactivated
serum in controls, for 40 min. bip and grp94 are increased in the
digitonin fraction of complement-treated GEC.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Translocation of ER stress proteins from ER to cytosol
A: Antibody-sensitized neo GEC and GEC that overexpress cPLA2
were incubated with 2.5% normal serum, or heat-inactivated serum in
controls, for 40 min (a representative experiment is shown in Fig.
1A). B: Antibody-sensitized neo GEC were incubated with
4.0% normal serum or heat-inactivated serum in controls (a
representative experiment is shown in Fig. 1B). The
preparation of cytosolic fractions is described in the legend to Fig.
1. Densitometry of bip and grp94 in cytosol is presented as normal
serum/heat-inactivated serum (-fold control).
|
|
Overexpression of cPLA2 in GEC enhanced complement-mediated
cytotoxicity (16). To assess the role of endogenous cPLA2
in complement-mediated injury, antibody-sensitized neo GEC were
incubated with serially increasing doses of complement in the presence
or absence of the cPLA2 inhibitor, MAFP (39). GEC injury
was quantified by monitoring release of LDH, a sensitive measure of
cell viability. Cytolysis was lower in the presence of MAFP (Table
III), suggesting that inhibition of
cPLA2 activity reduces complement-mediated injury.
View this table:
[in this window]
[in a new window]
|
Table III
Effect of the cPLA2 inhibitor, MAFP, on complement-mediated
cytolysis
Neo GEC were incubated with anti-GEC antibody (40 min) and normal serum
(or heat-inactivated serum in controls), in the presence or absence of
MAFP (25 µM) for 18 h. Complement-mediated cytolysis
was determined by measuring release of LDH into cell supernatants. MAFP
decreased the amount of complement-induced cytotoxicity
(p < 0.05 MAFP versus control). Values
represent five experiments.
|
|
Complement Enhances Expression of ER Stress Proteins in
GEC--
Assembly of C5b-9 may result in cell injury and may in
parallel activate mechanisms that restrict or limit the amount of
injury. Because C5b-9-induced activation of cPLA2 appeared
to disrupt the integrity of the ER membrane, as a consequence, the
function of the ER may have been altered. Thus, we proceeded to assess whether exposure of GEC to complement attack would lead to increased expression of ER stress proteins. Incubation of antibody-sensitized GEC
that overexpress cPLA2 with sublytic complement for 4 h resulted in increased mRNA levels of bip, grp94, and erp72 (Fig.
2A). The signals on Northern
blots were quantified by densitometric analysis. Bip, grp94, and erp72
mRNAs increased 1.7 ± 0.5-fold (n = 4, p < 0.02), 1.4 ± 0.2-fold (n = 6, p = 0.01), and 1.3 ± 0.2-fold (n = 4, p < 0.04), respectively, as
compared with control. Complement had no effect on the mRNA level
of the cytosolic stress protein, Hsp70 (not shown). Incubation of GEC
with C5b-9 induces an increase in [Ca2+]i and
activates protein kinases (17, 18). To determine the effect of
increased [Ca2+]i on bip, grp94, and erp72
mRNAs, GEC were incubated with the Ca2+ ionophore,
ionomycin, for 24 h. Ionomycin increased bip, grp94, and erp72
mRNAs (Fig. 2B), 1.7-, 2.3-, and 1.4-fold, respectively, as compared with control (two experiments). The effect of tunicamycin, one of the most potent inducers of ER stress proteins, is shown for
comparison (Fig. 2B). Tunicamycin increased bip, grp94, and erp72 mRNAs 5.5-, 5.4-, and 3.1-fold, respectively, as compared with control (two experiments).

View larger version (59K):
[in this window]
[in a new window]
|
Fig. 2.
Expression of ER stress protein mRNAs in
GEC. GEC that overexpress cPLA2 were incubated with
anti-GEC antibody and 2.5% normal serum (NS; to form
sublytic C5b-9), or heat-inactivated serum (HIS) in
controls, for 4 h (A). Total RNA was extracted and
subjected to Northern blotting. The control incubations demonstrate
that there is some basal expression of bip, grp94, and erp72 mRNAs
in GEC. Complement increased expression of bip, grp94, and erp72
mRNAs. B, GEC that overexpress cPLA2 were
incubated with ionomycin (Iono, 1 µM) or
buffer (Ctrl) for 24 h. Ionomycin increased bip, grp94,
and erp72 mRNAs. Tunicamycin (Tunic, 10 µg/ml, 24 h) was employed as a positive control in these experiments.
|
|
The next series of experiments addressed changes in protein levels of
bip, grp94, and erp72 in GEC, and the role of cPLA2. Incubation with ionomycin for 24 h increased ER stress protein expression (Fig. 3). The effect of
ionomycin was more prominent in the GEC that overexpress
cPLA2 (1.6- to 2.7-fold increases), as compared with neo
(1.3- to 1.7-fold increases). Tunicamycin (shown for comparison as a
positive control) was generally a more potent inducer of ER stress
proteins, and its effect was similar in neo GEC and GEC that
overexpress cPLA2 (1.7- to 2.9-fold increases). These
results indicate that the effect of ionomycin is, at least in part,
mediated via activation of cPLA2, whereas changes secondary to tunicamycin are cPLA2-independent. Chronic incubation of
antibody-sensitized GEC with complement (4-24 h) induced increases in
bip and grp94 protein expression (Fig. 4,
A-C). In these experiments, the increases in protein levels
(30-50% above control at 24 h) were evident mainly in the GEC
that overexpress cPLA2. An upward trend was present in neo
GEC, but the change did not reach statistical significance. It should
be noted that complement-induced increases in
[Ca2+]i are similar in magnitude in neo GEC and
in GEC that overexpress cPLA2 (17). Thus, the effect of
complement on bip and grp94 expression is, at least in part, mediated
via activation of cPLA2. To address the involvement of
endogenous cPLA2, antibody-sensitized neo GEC were
incubated with a higher concentration of complement, with or without
the cPLA2 inhibitor, MAFP. At the higher dose, significant
complement-induced increases in bip and grp94 protein levels were
evident in neo GEC, and the increases were inhibited by MAFP (Fig.
4D). The complement-induced increases in bip and grp94 were
functionally important, as demonstrated in the studies of
complement-induced injury (discussed below). We did not study the
effect of complement on erp72, because preliminary studies demonstrated
that complement-induced changes in erp72 protein levels were not
readily detectable.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of ionomycin on expression of ER
stress proteins in GEC. GEC that overexpress cPLA2 or
neo GEC were incubated with ionomycin (Iono, 1 µM) or buffer alone (control; Ctrl) for
24 h. Tunicamycin (Tunic, 10 µg/ml, 24 h) was
employed as a positive control. Cell lysates were immunoblotted with
antibodies to bip, grp94, or erp72. A, representative
immunoblot. B, densitometric quantification of immunoblots.
The control incubations demonstrate that there is some basal expression
of bip, grp94, and erp72 proteins in GEC. Ionomycin stimulated
increases in grp94, bip, and erp72, and the effect of ionomycin was
more prominent in the GEC that overexpress cPLA2. +,
p < 0.04 Iono versus Ctrl; *,
p < 0.001 Iono versus Ctrl and
p < 0.004 cPLA2 versus neo
(Iono-treated GEC); X, p = 0.06 Iono
versus Ctrl; ++, p < 0.001 Iono
versus Ctrl and p < 0.03 cPLA2
versus neo (Iono-treated GEC); **, p < 0.01 Iono versus Ctrl (5 experiments). Tunicamycin
(positive control) increased ER stress proteins in both neo GEC and GEC
that overexpress cPLA2.
|
|

View larger version (55K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of complement and cPLA2 on
expression of ER stress proteins in GEC. Antibody-sensitized GEC
that overexpress cPLA2 or neo GEC were incubated with 2.5%
normal serum (NS; to form sublytic C5b-9) or
heat-inactivated serum (HIS) in controls for 4, 6, or
24 h. Cell lysates were immunoblotted with antibodies to bip or
grp94. A, representative immunoblot. (On this gel, the grp94
band appeared to run as a doublet.) B, densitometric
quantification of immunoblots. Complement increased expression of bip
and grp94 significantly in GEC that overexpress cPLA2 (nine
experiments), whereas upward trends in bip and grp94 expression
occurred in neo GEC (six experiments). bip,
p < 0.002 NS versus HIS and
p = 0.05 cPLA2 versus neo (at
all time points); grp94, p < 0.001 NS
versus HIS and p < 0.035 cPLA2
versus neo (at all time points). The effect of tunicamycin
(Tunic) is shown for comparison (positive control).
C, assembly of C5b-9 is required for increased expression of
ER stress proteins. Antibody-sensitized GEC that overexpress
cPLA2 were incubated with 2.5% C8-deficient serum
(C8DS) or 2.5% C8-deficient serum reconstituted with
purified C8 (C8DS+C8) for 24 h. Cell lysates were
immunoblotted with antibodies to bip or grp94. A representative
immunoblot and densitometric quantification of immunoblots are
presented. C8DS+C8 increased expression of bip and grp94 significantly,
as compared with C8DS. bip, p < 0.0001 C8DS+C8 versus C8DS; grp94, p < 0.005 C8DS+C8 (six incubations). D, antibody-sensitized neo
GECs were incubated with 4.0% normal serum (NS; to form
sublytic C5b-9), 4.0% normal serum plus MAFP (25 µM), or
heat-inactivated serum (HIS) in controls, for 24 h. A
representative immunoblot and densitometric quantification of
immunoblots are presented. In control GEC (C), complement
increased bip and grp94 expression significantly (p < 0.01), whereas MAFP (M) inhibited the complement-induced
increases (five experiments).
|
|
Increases in the expression of ER stress proteins could be due to
cPLA2-mediated phospholipid hydrolysis and membrane injury or, secondarily, to signals triggered by cPLA2-generated
lipid products or their metabolites (prostanoids). GEC that overexpress cPLA2 were incubated with ionomycin or ionomycin plus the
cyclooxygenase inhibitor, indomethacin (10 µM), at a
concentration known to inhibit cyclooxygenase activity (20). Ionomycin
increased bip and grp94 expression (as in Fig. 3), and this effect was
not inhibited by indomethacin, suggesting that prostanoid production
was not involved in ER stress protein up-regulation (Fig.
5). Products of PLA2-induced phospholipid hydrolysis include AA and lysophospholipid. Addition of AA
(10 µM) did not enhance bip or grp94 expression (Fig. 5), although a similar concentration of AA can induce prostanoid generation in GEC (20). Lysophosphatidylcholine was also ineffective in enhancing
ER stress protein expression (Fig. 5). Thus, increases in bip and grp94
are most likely triggered by cPLA2-mediated phospholipid hydrolysis and membrane perturbation.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 5.
Products of cPLA2-induced
phospholipid hydrolysis do not increase expression of ER stress
proteins. A, representative immunoblot. B,
densitometric quantification of immunoblots. GEC that overexpress
cPLA2 were incubated with ionomycin (Iono, 1 µM), ionomycin + indomethacin (Indo, 10 µM), AA (10 µM), lysophosphatidylcholine
(LPC, 10 µM), tunicamycin (Tunic,
10 µg/ml; positive control), or buffer alone (Ctrl) for
24 h. Ionomycin increased bip and grp94 expression, and the effect
was not inhibited by indomethacin (*, p < 0.0005 versus control; +, p < 0.0001 versus control). bip and grp94 expression was not enhanced
by exogenously added AA, nor lysophosphatidylcholine (four
experiments).
|
|
Bip Antisense mRNA Expression and Effects on GEC
Injury--
To determine if complement-mediated induction of
ER stress proteins is functionally important, GEC were stably
transfected with bip antisense cDNA. Three clones that demonstrated
a reduction in tunicamycin-stimulated bip protein expression, as
compared with neo GEC were selected for further studies (Fig.
6A). In these bip antisense
clones, tunicamycin generally stimulated increases in grp94 and erp72
protein expression similar to neo GEC. The increases tended to be
blunted in one of the clones (Fig. 6A); however, previous
studies have reported that bip antisense mRNA expression may also
decrease induction of other ER stress proteins (33, 40). When the GEC
clones that express bip antisense mRNA were incubated with 1 µM ionomycin for 24 h, there was greater cytolysis
(release of LDH) in these clones, as compared with neo GEC (Table
IV). Thus, inhibition of the
ionomycin-induced increase in bip expression by bip antisense mRNA
results in enhanced GEC injury. There was also a tendency toward
greater cytolysis with 24-h tunicamycin incubation, but the difference
was not statistically significant (Table IV). By light microscopy, bip
antisense clones had normal morphology and proliferated at rates
similar to neo GEC under standard culture conditions.

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 6.
Effects of bip antisense mRNA on GEC
injury. A, effect of bip antisense mRNA on ER
stress protein expression. GEC were stably transfected with bip
antisense cDNA. The effect of bip antisense mRNA expression on
bip protein production was monitored by immunoblotting of lysates from
untreated (U) and tunicamycin (T)-treated GEC (10 µg/ml for 18 h). The figure shows three clones of GEC in which
bip protein induction by tunicamycin is reduced, as compared with neo
(bipAS-1-3). B, complement-mediated cytotoxicity
in GEC that express bip antisense mRNA. Neo GEC and three clones of
GEC that express bip antisense mRNA were incubated with anti-GEC
antibody (40 min), and normal serum (heat-inactivated serum in
controls) for 18 h. Complement-mediated cytotoxicity was
determined by measuring release of LDH into cell supernatants.
Complement induced greater cytotoxicity in the bipAS-1 and bipAS-3 GEC
(p < 0.015 bipAS-1 versus neo,
p < 0.003 bipAS-3 versus neo), whereas an
upward trend in cytotoxicity was evident in bipAS-2 (p = 0.078 bipAS-2 versus neo). Values represent five
experiments. There were no significant differences in background LDH
release, i.e. in incubations with heat-inactivated serum
(not shown).
|
|
View this table:
[in this window]
[in a new window]
|
Table IV
Effect of ionomycin and tunicamycin on LDH release in GECs that stably
express bip antisense mRNA
neo and bip antisense (bipAS) GEC were incubated with ionomycin, 1 µM (four experiments), or tunicamycin, 10 µg/ml (six
experiments). LDH release (reflecting cell lysis) was determined after
24 h.
|
|
The bip antisense clones and neo GEC were sensitized with antibody and
incubated with serially increasing doses of complement that induced
minimal to moderate cell lysis at 18 h. This protocol allows for
C5b-9 to increase ER stress protein expression (Fig. 4), but with
increasing incubation time and complement dose, a portion of the cells
will undergo lysis. After 18 h of incubation, lysis (LDH release)
was consistently greater in the GEC clones that express bip antisense
mRNA (Fig. 6B). Thus, attenuation of the C5b-9-induced
increase in bip expression by bip antisense mRNA results in
enhanced cytolysis, indicating that induction of bip plays a
functionally important role in limiting the amount of
complement-dependent injury. In other experiments, neo GEC and the GEC that express bip antisense mRNA were incubated with antibody and serially increasing doses of complement for only 40 min.
During brief incubation, there is insufficient time for C5b-9 to
increase ER stress protein expression. After 40 min, complement lysis
was not enhanced in the bip antisense clones and actually tended to be
lower in these clones, as compared with neo (Table
V). Thus, basal expression of ER stress
proteins did not modulate complement cytotoxicity. Moreover, these
experiments indicate that expression of bip antisense mRNA in GEC
does not exacerbate complement-induced lysis nonspecifically.
View this table:
[in this window]
[in a new window]
|
Table V
Complement-mediated cytolysis (acute incubation) in GECs that express
bip antisense mRNA
neo GEC and three clones of GECs that express bip antisense mRNA
were incubated with anti-GEC antibody (40 min) and normal serum (or
heat-inactivated serum in controls) for 40 min. Complement-mediated
cytolysis was determined by measuring release of LDH into cell
supernatants. There were no significant increases in cytolysis in the
bip antisense clones, as compared with neo. Values represent 6-10
experiments.
|
|
In the next series of experiments, we assessed whether other stimuli
that induce ER stress protein expression would affect complement-mediated GEC injury. We observed that some stimuli provided
protective effects, whereas others enhanced complement lysis. GEC in
culture are particularly sensitive to the cytotoxic effect of puromycin
aminonucleoside (36), and injection of this compound into rats may
induce GEC injury and proteinuria in vivo (41). Incubation
of cultured GEC with puromycin aminonucleoside increased expression of
bip at 2 and 4 h, however, expression returned to basal levels at
24 h (Fig. 7A). In GEC
that were preincubated with puromycin aminonucleoside for 3 h,
complement-dependent cytolysis was reduced significantly
(Fig. 7B). We then examined the effects of pretreatment with
tunicamycin and ionomycin (Fig. 3). Unlike puromycin aminonucleoside,
24-h preincubation with tunicamycin (a potent inducer of ER stress
proteins) enhanced complement-mediated lysis (Table
VI). Preincubation with tunicamycin for
only 6 h did not affect complement-mediated GEC injury
significantly, but this shorter preincubation time did not increase
expression of ER stress proteins consistently (data not shown).
Ionomycin pretreatment tended to enhance complement-mediated injury,
although the change was not statistically significant (Table VI). We
also evaluated if exposure of GEC to an in vitro model of
ischemia-reperfusion injury (chemical anoxia) would increase expression
of ER stress proteins and protect from subsequent complement attack.
Incubation of GEC with 2-deoxyglucose + antimycin A for 90 min (to
inhibit glycolytic and/or oxidative metabolism), followed by
re-exposure to glucose-replete culture medium for 24 h resulted in
increased expression of bip and grp94 (Fig.
8). This protocol did not protect, but
rather enhanced, complement-mediated injury significantly (Table
VI).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 7.
Effects of puromycin aminonucleoside on bip
expression (A) and complement-mediated GEC injury
(B). A, GEC that overexpress
cPLA2 were incubated with puromycin aminonucleoside
(PA; 50 µg/ml) for 2, 4, or 24 h. An increase in bip
expression is evident at 2 and 4 h (representative immunoblot).
The effect of tunicamycin is shown for comparison. B, GEC
were preincubated without (Ctrl) and with puromycin
aminonucleoside for 3 h (to induce bip expression) and were then
incubated with antibody and normal serum (heat-inactivated serum in
controls). LDH release (reflecting cell lysis) was determined after 40 min. Pretreatment with puromycin aminonucleoside reduced
complement-dependent lysis significantly (p < 0.002 PA versus Ctrl, five experiments).
|
|
View this table:
[in this window]
[in a new window]
|
Table VI
Effects of tunicamycin, ionomycin, and chemical anoxia on
complement-mediated GEC injury
GECs that overexpress cPLA2 were preincubated with tunicamycin
(10 µg/ml, 24 h), ionomycin (1 µM, 24 h), or
deoxyglucose (DG) + antimycin A (as in Fig. 8) to induce
expression of ER stress proteins. Then, GECs were incubated with
antibody, followed by 5, 10, or 15% normal serum (or heat-inactivated
serum in controls). LDH release (reflecting cell lysis) was determined
after 40 min. Pretreatment with tunicamycin or prior exposure to
chemical anoxia enhanced complement-dependent lysis
significantly (p < 0.01 tunicamycin versus
untreated, four experiments; p < 0.04 DG + antimycin A versus untreated, three experiments). A small
upward trend in complement-dependent lysis was evident with
ionomycin pretreatment (five experiments).
|
|

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 8.
Effect of chemical anoxia on ER stress
protein expression (representative immunoblot). GEC were incubated
with glucose-free measurement buffer for 40 min at 37 °C. Then, GEC
were incubated with 10 mM 2-deoxyglucose (DG),
10 mM 2-deoxyglucose + 10 µM antimycin A, or
buffer alone (Ctrl). Supernatants were removed after 90 min
at 37 °C, and GEC were placed into culture medium for 24 h.
Lysates were immunoblotted with antibodies to bip or grp94.
Deoxyglucose with or without antimycin A induced an increase in bip.
There was a smaller increase in grp94 with deoxyglucose + antimycin A. The effect of tunicamycin is shown for comparison.
|
|
Expression of ER Stress Proteins Is Enhanced in GEC Injury in
Vivo--
The above experiments demonstrated that C5b-9 increases bip
and grp94 protein expression in cultured GEC, but it is important to
determine if analogous changes occur in C5b-9-mediated GEC injury
in vivo. To address this question, we assessed levels of bip
and grp94 in PHN, where GEC injury is due to C5b-9 assembly, and is
associated with cPLA2 activation and production of
prostanoids. In our model of PHN, proteinuria begins to appear at
approximately day 7 and is well-established at days 13 and 14 (see
below). On day 14, expression of glomerular bip and grp94 was increased
in rats with PHN, as compared with control (Fig.
9, A and B).
Increases in levels of bip and grp94 proteins were not detected
consistently on days 3 and 7 (data not shown). By analogy to puromycin
aminonucleoside, GEC in vivo are sensitive to the cytotoxic
effects of adriamycin, and injection of rats with adriamycin may lead
to GEC injury, in association with proteinuria (41). A second group of
rats was injected with a subnephritogenic dose of adriamycin,
i.e. a dose that did not induce proteinuria for up to 14 days. Glomeruli of these rats showed a significant increase in grp94
expression, whereas bip expression showed an upward trend (Fig.
9B). Thus, levels of ER stress proteins also increased when
GEC were injured in vivo by a toxin-mediated mechanism.
Moreover, the results with adriamycin suggest that development of
proteinuria is not essential for enhanced ER stress protein
expression in GEC. Finally, injection of rats with tunicamycin enhanced
glomerular expression of bip and grp94 (Fig. 9C), without
inducing proteinuria.

View larger version (69K):
[in this window]
[in a new window]
|
Fig. 9.
Expression of ER stress proteins in
vivo. Glomeruli were isolated from normal rats
(control) and from rats with PHN on day 14. Glomerular lysates were
immunoblotted with antibodies to bip or grp94 (A,
representative immunoblots; B, densitometric
quantification). bip and grp94 expression was increased in glomeruli
isolated from rats with PHN, as compared with control (*,
p < 0.002; +, p < 0.005 PHN
versus control; 7-9 rats per group). B also
shows the densitometric quantification of grp94 and bip expression in
rats injected with subnephritogenic adriamycin, 6 mg/kg intravenously
(ADR, day 14, **, p < 0.001 adriamycin
versus control; 9-12 rats per group), as well as in rats
injected with tunicamycin, 1 mg/kg intraperitoneally (Tun,
24 h, the dots represent the values of two individual
rats in each group).
|
|
The experiments presented in Figs. 6 and 7 show that ER stress proteins
restrict complement-mediated cytolysis in cultured GEC. In the next
series of experiments, we assessed whether stimuli shown to induce ER
stress protein expression would limit C5b-9-mediated GEC injury
(i.e. proteinuria) in vivo. Rats were treated
with a subnephritogenic dose of adriamycin, or tunicamycin, prior to the induction of PHN. Proteinuria developed in untreated rats with PHN
(on days 7, 9, and 13), whereas the amount of proteinuria was
significantly lower in the rats with PHN that had been pretreated with
adriamycin or tunicamycin (Fig. 10).
Thus, increased ER stress protein expression can reduce C5b-9-mediated
GEC injury in vivo. By immunofluorescence microscopy and/or
immunoblotting, there were no apparent differences in the amounts of
glomerular sheep antibody IgG, rat IgG, and rat C3 among the three
groups of rats (Fig. 11 and Table
VII), indicating that adriamycin and
tunicamycin did not decrease proteinuria by reducing the amount of
glomerular antibody deposition. Serum creatinine was not significantly
different among the three groups of rats, indicating that most likely
there were no significant differences in renal function (Table VII). Urine volumes ranged from 5.6 to 22.5 ml/24 h, and there was no consistent pattern among groups (data not shown). In the PHN rats pretreated with adriamycin or tunicamycin, we did not detect further increases in glomerular levels of bip and grp94 (day 14), as compared with the PHN-untreated group (data not shown).

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 10.
Pretreatment of rats with a subnephritogenic
dose of adriamycin or tunicamycin reduces proteinuria in PHN. Rats
were untreated or were injected with adriamycin, 6 mg/kg intravenously
(ADR), or tunicamycin, 1 mg/kg intraperitoneally
(Tun) to up-regulate ER stress proteins (Fig. 9). Four days
later, rats were injected with anti-Fx1A to induce PHN (day 0). Urine
protein was measured on days 0, 7, 9, and 13. Compared with the
PHN-untreated group (4 rats), proteinuria was significantly lower in
the adriamycin (p < 0.005, 3 rats) and tunicamycin
groups (p < 0.025, 3 rats).
|
|

View larger version (110K):
[in this window]
[in a new window]
|
Fig. 11.
Glomerular deposition of sheep
(Sh) IgG, rat IgG, and rat C3 in rats with PHN that
were pretreated with adriamycin or tunicamycin, or were untreated.
Kidney sections were stained with fluorescein-conjugated antibodies and
visualized using immunofluorescence microscopy (×250
magnification).
|
|
View this table:
[in this window]
[in a new window]
|
Table VII
Glomerular antibody and C3 deposition and serum creatinine measurements
in PHN
Rats with PHN were untreated (4 rats) or were pretreated with
adriamycin (ADR; 3 rats) or tunicamycin (Tun; 3 rats). All measurements were performed on day 14 (see Fig. 10).
Glomeruli were isolated, and the amounts of sheep IgG and rat IgG were
assessed by immunoblotting and quantified by densitometry. Values
represent densitometry in arbitrary units. Kidney sections were stained
with fluorescein-conjugated specific antibodies, and the amounts of
glomerular sheep IgG, rat IgG, and rat C3 were assessed by
immunofluorescence microscopy (IF) and quantified (see
"Methods"). Values represent times required to collect images by
the photomultiplier and camera (seconds) and are inversely proportional
to fluorescence intensity. For all parameters, there are no significant
differences among groups.
|
|
 |
DISCUSSION |
In this study, we show that cPLA2 activation in GEC
was associated with leakage of luminal ER stress proteins (bip and
grp94) into the cytosol (Fig. 1), suggesting that
cPLA2-induced phospholipid hydrolysis resulted in
impairment of ER membrane integrity. These results are in keeping with
our previous studies, which demonstrated that overexpression of
cPLA2 in GEC exacerbates complement-mediated cytotoxicity
(16) and that complement-induced activation of cPLA2 leads
to phospholipid hydrolysis at the membrane of the ER (29).
Furthermore, we show that inhibition of endogenous cPLA2
can attenuate complement-mediated cytotoxicity in GEC (Table III). The
mechanism of bip and grp94 leakage from the ER may have involved
dysregulation of ER protein pores (42), but it will require further
delineation. Another consideration is that complement-induced cPLA2 activation was associated with increased retrograde
translocation of abnormal proteins from the ER (the abnormal
proteins being coupled with bip or grp94) (42), although it is less
likely that retrograde translocation could have occurred in an acute time frame. Impairment of ER membrane integrity could potentially be
injurious by causing leakage of Ca2+ and other ER
luminal components as well as impairment in ER Ca2+
uptake. Although association of cPLA2 with membranes of
cell organelles has been established in other cell types (27), there is
little information on potential damage to organelle membranes due to
phospholipid hydrolysis. In addition to the present study, overexpression of cPLA2 in LLCPK1 kidney
epithelial cells was associated with disruption of the Golgi (43).
Chronic incubation of GEC with complement (4-24 h) enhanced expression
of bip and grp94 mRNAs and proteins (Figs. 2 and 4), although there
was no detectable increase in the cytosolic stress protein, Hsp70. The
increases in ER stress proteins were dependent on C5b-9 assembly (Fig.
4C). At lower doses, complement-induced increases in bip and
grp94 expression were seen mainly in the GEC that overexpress
cPLA2, but at a higher dose, expression was also induced in
neo GEC, and the increases were blocked with MAFP (Fig. 4). Thus,
increases in bip and grp94 were, at least in part, dependent on the
activation of cPLA2. Further support for the role of
cPLA2 in ER stress protein induction was provided by
experiments in which GECs were incubated chronically with the
Ca2+ ionophore, ionomycin. bip and grp94 protein expression
was enhanced by ionomycin, and the changes were significantly greater
in the GEC that overexpress cPLA2 (Fig. 3).
Increases in ER stress proteins were not limited to cultured GEC but
also occurred in vivo. Using the PHN model of C5b-9-induced GEC injury, it was demonstrated that glomerular bip and grp94 proteins
were up-regulated in proteinuric rats with PHN (day 14), as compared
with normal controls (Fig. 9). Rats with PHN show increased glomerular
activity of cPLA2 and AA metabolites (19, 20). At present,
there are no specific inhibitors of cPLA2 that can be used
in experimental animals (44). Thus, although bip and grp94
up-regulation in PHN is associated with the activation of
cPLA2, proof for the functional importance of
cPLA2 in vivo will require development of
suitable cPLA2 inhibitors. Moreover, we have not been
successful in establishing a proteinuric model of PHN in mice, and,
consequently, cPLA2-null mice (45) could not be used to
address the functional role of cPLA2.
The ER serves as a site for folding, assembly, and degradation of
proteins (30-32). Membrane and secreted proteins are translocated into
the lumen of the ER shortly after initiation of synthesis, and resident
ER luminal proteins, including bip and grp94, mediate protein folding.
Moreover, bip and grp94 are believed to bind to misfolded or abnormal
proteins and prevent their aggregation, either by rescuing such
proteins from irreversible damage, or by increasing their
susceptibility to proteolytic attack. Other ER proteins, including
erp72, may participate in disulfide isomerization. Perturbation of the
ER by stimuli, including accumulation of mutant proteins or
Ca2+ depletion, may increase expression of ER stress
proteins. In yeast, misfolded proteins in the ER lead to activation of
Ire1p endonuclease (31, 32). Ire1p splices HAC1 (homologous to
activating transcription factor (ATF) and CREB) mRNA in the
nucleus, which is then religated, exits the nucleus, and is translated
into Hac1p transcription factor. Hac1p translocates to the nucleus,
binds to the unfolded response element, and induces expression of
ER stress proteins. The mammalian unfolded protein response,
although analogous to yeast, is more complex and appears to
involve additional pathways and effectors (46).
C5b-9-induced sublethal cell injury may lead to a decline in cellular
ATP, mitochondrial lipid perturbation, or loss of mitochondrial membrane potential (47-49), whereas at high doses, C5b-9 can induce mitochondrial damage and cell necrosis (50). Based on biochemical and
morphologic observations (36, 49), it is likely that, during
complement-dependent GEC injury, integral membrane and secretory proteins are altered. Such proteins may include integrins, transporters, and/or cell junctional proteins, and these alterations may contribute to the permselectivity defect of the glomerular capillary wall in PHN. Besides inducing cell injury, C5b-9 assembly leads to activation of mechanisms that restrict injury or facilitate recovery of cells from complement attack. One such mechanism of protection is "ectocytosis" (shedding) of C5b-9 complexes from cell
membranes (1, 2). The present study identifies another mechanism that
limits complement attack (Figs. 6, 8, and 10). Expression of bip
antisense mRNA in GEC reduced stimulated bip protein expression, and when these GEC were incubated with complement for 18 h,
cytolysis was enhanced, as compared with neo GEC (Fig. 6). Thus,
induction of ER stress proteins is an important novel mechanism of
protection from sustained complement attack. The capability of the GEC
to recover or limit the severity of complement attack may depend on its
capacity to re-synthesize or reassemble integral membrane proteins,
which may require the presence of bip or grp94. Induction of these ER
stress proteins during complement attack may also limit accumulation of
abnormal proteins and help sustain physiological functions and
viability (31, 32).
Exposure of cells to mild stress, sufficient to induce up-regulation of
ER stress proteins, may be protective to additional insults (33, 34),
although progression to cell death may occur if the stress is more
intense or prolonged (35). The present study demonstrates that
preincubation of cultured GEC with a sublethal dose of puromycin
aminonucleoside increased bip expression and protected GEC from
complement attack (Fig. 7). On the other hand, prior exposure of
cultured GEC to ischemia-reperfusion injury (chemical anoxia), despite
increasing ER stress proteins (Fig. 8), exacerbated
complement-mediated cytotoxicity (Table VI). However, cellular
effects of ischemia and reperfusion are complex and are manifested by a
variety of changes that include a decline in cellular ATP levels,
alterations of cellular redox state and perturbations in intracellular
Ca2+ homeostasis (34). In earlier studies, pretreatment
with tunicamycin protected renal tubular epithelial cells from chemical
anoxia or toxin-induced injury (33, 34). In contrast, ionomycin and tunicamycin, despite increasing ER stress proteins, either had no
effect or exacerbated complement-mediated cytotoxicity in cultured GEC (Table VI). These compounds may have induced multiple alterations in GEC leading to substantial injury, and with subsequent exposure to
complement, the cells could not withstand the additional stress. However, it is not clear why the effect of tunicamycin was cytotoxic in
culture, but protective in PHN. This question will require further study.
The functional role of ER stress proteins in cultured GEC was
applicable to GEC injury in vivo. Induction of ER stress
proteins by pretreatment with a subnephritogenic dose of adriamycin or tunicamycin significantly reduced proteinuria in PHN (Fig. 10), independently of changes in glomerular immunoglobulin or complement deposition (Fig. 11 and Table VII). It should be noted that, although tunicamycin was reported to induce a renal lesion resembling acute tubular necrosis in mice (51), the PHN rats that had been pretreated with tunicamycin had no significant alterations in renal function (Table VII). Our observations provide a rationale for developing non-toxic methods to induce expression of ER stress protein in vivo, which may eventually have applications for therapy of
glomerular disease. The importance of these results extends beyond
complement-induced GEC injury. For example, preinduction of ER stress
proteins prior to xenotransplantation may potentially be a means of
reducing hyperacute xenograft rejection, which is
complement-dependent (52).
 |
FOOTNOTES |
*
This work was supported in part by research grants from the
Canadian Institutes of Health Research (CIHR) and the Kidney Foundation of Canada.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Holds a Scholarship from the Fonds de la Recherche en
Santé du Québec. To whom correspondence should be
addressed: Division of Nephrology, Royal Victoria Hospital, 687 Pine
Ave. West, Montreal, Quebec H3A 1A1, Canada. Tel.: 514-398-8148; Fax:
514-982-0897; E-mail: andrey.cybulsky@mcgill.ca.
Holds a CIHR Scholarship.
**
Recipient of a CIHR Studentship.

Recipient of a Fellowship from the McGill University Health
Centre Research Institute.
Published, JBC Papers in Press, August 20, 2002, DOI 10.1074/jbc.M204694200
 |
ABBREVIATIONS |
The abbreviations used are:
PHN, passive Heymann
nephritis;
AA, arachidonic acid;
[Ca2+]i, cytosolic free Ca2+ concentration;
cPLA2, cytosolic phospholipase A2;
GEC, glomerular epithelial
cells;
LDH, lactate dehydrogenase;
MAFP, methyl arachidonyl
fluorophosphonate;
ER, endoplasmic reticulum;
grp, glucose-related
protein;
NS, normal serum;
HIS, heat-inactivated serum.
 |
REFERENCES |
| 1.
|
Morgan, B. P.
(1992)
Curr. Topics. Microbiol. Immunol.
178,
115-140[Medline]
[Order article via Infotrieve]
|
| 2.
|
Nicholson-Weller, A.,
and Halperin, J. A.
(1993)
Immunol. Res.
12,
244-257[Medline]
[Order article via Infotrieve]
|
| 3.
|
Niculescu, F.,
Rus, H.,
and Shin, M. L.
(1994)
J. Biol. Chem.
269,
4417-4423[Abstract/Free Full Text]
|
| 4.
|
Niculescu, F.,
Rus, H.,
van Biesen, T.,
and Shin, M. L.
(1997)
J. Immunol.
158,
4405-4412[Abstract]
|
| 5.
|
Rus, H. G.,
Niculescu, F.,
and Shin, M. L.
(1996)
J. Immunol.
156,
4892-4900[Abstract]
|
| 6.
|
Halperin, J. A.,
Taratuska, A.,
and Nicholson-Weller, A.
(1993)
J. Clin. Invest.
91,
1974-1978[Medline]
[Order article via Infotrieve]
|
| 7.
|
Shankland, S. J.,
Pippin, J. W.,
and Couser, W. G.
(1999)
Kidney Int.
56,
538-548[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Kilgore, K. S.,
Schmid, E.,
Shanley, T. P.,
Flory, C. M.,
Maheswari, V.,
Tramontini, N. L.,
Cohen, H.,
Ward, P. A.,
Friedl, H. P.,
and Warren, J. S.
(1997)
Am. J. Pathol.
150,
2019-2031[Abstract]
|
| 9.
|
Tischer, C. G.,
and Couser, W. G.
(2000)
J. Am. Soc. Nephrol.
10,
183-188
|
| 10.
|
Cybulsky, A. V.,
Foster, M. H.,
Quigg, R. J.,
and Salant, D. J.
(2000)
in
The Kidney: Physiology and Pathophysiology
(Seldin, D. W.
, and Giebisch, G., eds), 3rd Ed.
, pp. 2645-2697, Lippincott-Raven Publishers, Philadelphia
|
| 11.
|
Cybulsky, A. V.,
Rennke, H. G.,
Feintzeig, I. D.,
and Salant, D. J.
(1986)
J. Clin. Invest.
77,
1096-1107[Medline] |